Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 3;16(2):e53523.
doi: 10.7759/cureus.53523. eCollection 2024 Feb.

Delivering Therapy to the Olfactory Cleft: A Comparison of the Various Methods of Administering Topical Nasal Medications

Affiliations

Delivering Therapy to the Olfactory Cleft: A Comparison of the Various Methods of Administering Topical Nasal Medications

Patricia T Jacobson et al. Cureus. .

Abstract

Background and objective Chronic rhinosinusitis (CRS) is an inflammatory condition affecting the nasal mucosa, and it causes olfactory dysfunction (OD) in up to 78.2% of patients. Corticosteroids are the mainstay of treatment to shrink nasal polyposis, reduce inflammation, and improve olfactory function. While many delivery methods for topical nasal corticosteroids exist, there is scarce data on the efficacy of the various medication delivery methods to the olfactory cleft (OC). In light of this, this study aimed to compare the following delivery methods to the OC: conventional nasal spray (NS), nasal drops in the Kaiteki position (KP), and exhalation delivery system (EDS). Methods We evaluated 16 sinonasal cavities from eight cadaver specimens in this study. Each sinonasal cavity was administered fluorescein dye solution via NS, KP, and EDS. Following administration, nasal endoscopy was employed to capture staining patterns in the OC. OC staining was rated with scores ranging from 0 (no staining) to 3 (heavy staining) after each administration of dye solution. Mean OC staining ratings were calculated and compared using the Kruskal-Wallis rank sum test and the Wilcoxon signed-rank test. Results The mean OC staining score for the different delivery methods was as follows - NS: 1.095 ± 1.008, EDS: 0.670 ± 0.674, and KP: 2.038 ± 1.097. Nasal drops in the KP had a significantly higher staining score compared to NS (p=0.041) and EDS (p=0.003). However, there was no significant difference in staining scores between NS and EDS. Conclusions Nasal drops in the KP are more effective at reaching the OC than NS or EDS and should be considered as a first-line modality for administering topical medications when treating OD.

Keywords: chronic rhinosinusitis; exhalation delivery system; kaiteki; nasal spray; olfactory cleft.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. The Kaiteki position for the administration of nasal drops
This method involves the patient lying on their side with the chin turned 20°-40° upwards and the head tilted 20°-30° downwards
Figure 2
Figure 2. Examples of OC staining
EDS: exhalation delivery system; KP: Kaiteki position; NS: nasal spray; OC: olfactory cleft
Figure 3
Figure 3. Box plot showing average OC staining score for NS (n=15), EDS (n=16), and KP (n=16)
Each dot represents the average rating for a single cadaver EDS: exhalation delivery system; KP: Kaiteki position; NS: nasal spray; OC: olfactory cleft

References

    1. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. Sedaghat AR, Kuan EC, Scadding GK. J Allergy Clin Immunol Pract. 2022;10:1395–1403. - PubMed
    1. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Kohli P, Naik AN, Harruff EE, Nguyen SA, Schlosser RJ, Soler ZM. Laryngoscope. 2017;127:309–320. - PMC - PubMed
    1. Burden of disease in chronic rhinosinusitis with nasal polyps. Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. J Asthma Allergy. 2021;14:127–134. - PMC - PubMed
    1. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Orlandi RR, Kingdom TT, Smith TL, et al. Int Forum Allergy Rhinol. 2021;11:213–739. - PubMed
    1. Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Djupesland PG. Drug Deliv Transl Res. 2013;3:42–62. - PMC - PubMed

LinkOut - more resources